Abstract 4366509: Total Carotid Artery Calcium Score on Standard-of-care Oncologic Computed Tomography Scans Predicts Radiation-induced Carotid Artery Disease and its Sequelae in Patients with Oropharyngeal Cancer

T Taher Kapadia (MD Anderson Cancer Center, Houston , Texas, United States) D Dhawal Sanjay Bandrey (MD Anderson Cancer Center, Houston , Texas, United States) B Bhumiben Patel (MD Anderson Cancer Center, Houston, Texas, United States) P Patrik Joan Van Bergen Diaz (University of Barcelona, Barcelona, Spain) J Jennifer Shen (MD Anderson Cancer Center, Pearland, Texas, United States) G Gabrielle Mbagwu (MD Anderson Cancer Center, Houston, Texas, United States) S Stephen Patin (MD Anderson Cancer Center, Houston , Texas, United States) A Andres Hughes (MD Anderson Cancer Center, Houston, Texas, United States) J Juhee Song (UT MD Anderson Cancer Center, Houston, Texas, United States) R Ruitao Lin (MD Anderson Cancer Center, Houston, Texas, United States) J Junichi Abe (University of Texas MD Anderson Can, Houston, Texas, United States) N Nicolas Palaskas (UT MD Anderson Cancer Center, Houston, Texas, United States) G Gregory Gladish A Amy Moreno (MD Anderson Cancer Center, Houston , Texas, United States) M Mohamed Naser K Katherine Hutcheson (MD Anderson Cancer Center, Houston , Texas, United States) D David Rosenthal (MD Anderson Cancer Center, Houston, Texas, United States) E Elie Mouhayar (MD Anderson Cancer Center, Houston, Texas, United States) A Anita Deswal C Clifton Fuller C Claire Viguet (Mcgovern Medical School, Houston, Texas, United States) E Efstratios Koutroumpakis (UT MD Anderson Cancer Center, Houston, Texas, United States)

Abstract

Introduction: Radiation therapy (RT) induced carotid artery disease (RICAD) is a significant contributor to morbidity and mortality of oropharyngeal cancer (OPC) survivors. Pre-existing carotid atherosclerosis is likely a risk factor for accelerated development of RICAD.Its evaluation prior to RT is not currently standard practice. This study aimed to utilize standard of care (SOC) oncologic pre-RT CT scans to quantify carotid calcific atherosclerosis and assess the role of carotid artery calcium score (CaACS) in predicting RICAD and its sequalae. Methods: Patients with OPC treated with RT at a tertiary center during 2016-19 were identified. SOC oncologic pre-RT CT of the neck with contrast was used to estimate CaACS utilizing the CT Cardiac package of SyngoVia (Siemens Healthcare). To separate calcified plaque from contrast, density threshold of 230 HU was used.Bilateral common and internal carotid arteries were evaluated to the C1 vertebra. Patients were split into three groups based on CaACS distribution:low (values ≤ median) as reference group,medium(values between median and 75th percentile),and high (values >75th percentile). Results: A total of 271 patients were included (mean age 61 ± 9.8, 88% male).Smoking was reported in 57%, hypertension (HTN) in 53%, dyslipidemia (DLD) in 43%, and diabetes mellitus (DM) in 14%,while 34% were on a statin prior to RT. Total median CaACS was 10.8 AU (IQR 0-140.6) with 46% having a score of 0. During a median follow up of 6.4 years (IQR 6.3-6.6), 41% developed new or worsened carotid atherosclerosis, 3.7% carotid artery stenosis >50%, 2.6% TIA or stroke, and 17% died without new or worsened carotid atherosclerosis. In a multivariate cause-specific Cox regression analysis, high CaACS was significantly associated with increased risk of the composite outcome of worsened carotid atherosclerosis, >50% stenosis, TIA or stroke (HR 2.18,95% CI[1.34-3.54]) compared to low CaACS. Hypertension was also associated with the composite outcome (2.26[1.49-3.41]) while no significant associations were noted with age, smoking, DLD, DM, or statin use. Fine-Gray analysis showed similar results. Conclusion: In our cohort of patients with OPC, high CaACS and history of HTN prior to RT, were significantly associated with development of RICAD. Quantification of carotid artery calcific atherosclerosis utilizing SOC oncologic CT imaging may assist with patient risk stratification, guide surveillance and potentially mitigate RICAD in OPC survivors.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (22)

T

Taher Kapadia

MD Anderson Cancer Center, Houston , Texas, United States

D

Dhawal Sanjay Bandrey

MD Anderson Cancer Center, Houston , Texas, United States

B

Bhumiben Patel

MD Anderson Cancer Center, Houston, Texas, United States

P

Patrik Joan Van Bergen Diaz

University of Barcelona, Barcelona, Spain

J

Jennifer Shen

MD Anderson Cancer Center, Pearland, Texas, United States

G

Gabrielle Mbagwu

MD Anderson Cancer Center, Houston, Texas, United States

S

Stephen Patin

MD Anderson Cancer Center, Houston , Texas, United States

A

Andres Hughes

MD Anderson Cancer Center, Houston, Texas, United States

J

Juhee Song

UT MD Anderson Cancer Center, Houston, Texas, United States

R

Ruitao Lin

MD Anderson Cancer Center, Houston, Texas, United States

J

Junichi Abe

University of Texas MD Anderson Can, Houston, Texas, United States

N

Nicolas Palaskas

UT MD Anderson Cancer Center, Houston, Texas, United States

G

Gregory Gladish

A

Amy Moreno

MD Anderson Cancer Center, Houston , Texas, United States

M

Mohamed Naser

K

Katherine Hutcheson

MD Anderson Cancer Center, Houston , Texas, United States

D

David Rosenthal

MD Anderson Cancer Center, Houston, Texas, United States

E

Elie Mouhayar

MD Anderson Cancer Center, Houston, Texas, United States

A

Anita Deswal

C

Clifton Fuller

C

Claire Viguet

Mcgovern Medical School, Houston, Texas, United States

E

Efstratios Koutroumpakis

UT MD Anderson Cancer Center, Houston, Texas, United States